entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,0.8647638312954,1.97536613234893,2.19770406465582,0.898831723577981,0.368742299768523,0.921479865892211,NA
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,0.198687070346577,-0.893695659167385,4.0804728567969,-0.219017670385613,0.826636282942951,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,0.904132857642743,3.3021310607275,2.45769397969332,1.34358918889469,0.179081267400224,0.516092185730995,A549
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,1.37682728422135,-2.56525302773257,1.96568205789776,-1.30501930229553,0.19188627520054,0.986418245486816,A549
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,4.2491393820646,1.99690244974816,1.51003190405914,1.32242401261871,0.186026997187558,0.412352876462489,A549
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0,NA,NA,NA,NA,NA,sigmoid colon organoid
100534611,TM4SF19-DYNLT2B,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0,NA,NA,NA,NA,NA,sigmoid colon organoid
